Related Experiment Video
Updated: May 18, 2026

Elevated Plus Maze Test Combined with Video Tracking Software to Investigate the Anxiolytic Effect of Exogenous Ketogenic Supplements
Published on: January 7, 2019
Psychopharmacologic treatment for pediatric anxiety disorders
Todd E Peters1, Sucheta Connolly
1Department of Psychiatry, Division of Child and Adolescent Psychiatry, Vanderbilt University School of Medicine, Vanderbilt Psychiatric Hospital, Nashville, TN 37212-8645, USA. todd.peters@vanderbilt.edu
Abstract:
Anxiety is an innate emotion that all humans experience, especially during early childhood in periods of significant growth and development. Treatment strategies exist for anxiety disorders that cause significant dysfunction and impairment in youth. This article provides a current overview of the literature on psychopharmacologic management of pediatric anxiety disorders. Potential side effects and complications of psychotropic medications are reviewed. The treatment of anxiety disorders in patients with comorbid conditions is explored, addressing the impact on treatment course and pharmacologic recommendations. A clinical vignette describing a 10-year-old boy with increasing anxiety is presented describing in-hospital and outpatient treatment and therapies.
Related Concept Videos
Anxiolytic Drugs: Overview
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.
Drug Therapy
Antianxiety Medications
Anxiolytic Drugs: Benzodiazepines and Buspirone
Behavior Therapy
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
Panic Disorder
Psychosis: Goals of Pharmacotherapy